Treatment for neuroendocrine cancer
Peptide receptor radionuclide therapy (PRRT) is a type of radioisotope therapy. These treatments use radioactive medicines to treat some types of cancer. PRRT is also called:
radioligand therapy
molecular radiotherapy
targeted radiotherapy
radio labelled treatment
targeted radionuclide therapy
PRRT is a possible treatment for some NETs that start in the or the . It is not a treatment for NECs.
Radioisotope therapy uses radioactive medicines to treat some cancer types.
The radioisotope travels around your body in the bloodstream to the area where the cancer is. The radioactive part is called an isotope. It may be attached to another substance, which is designed to take the isotope to the cancer.
The cancer cells take up the radioisotope and get a high dose of radiation, which destroys them. The healthy cells receive a low dose or no radiation.
Read about radioisotope therapy
There are different types of radioisotope therapy, including PRRT.
Some neuroendocrine cells have proteins ( ) on the outside of them. These are called receptors. The somatostatin attaches to these receptors and causes changes in the cell. For example, they may tell the cell to slow down the production of hormones.
Special scans can check whether your NET has these receptors. If your NET has somatostatin receptors, doctors can use these receptors to target radioisotope therapy.
In the laboratory, doctors attach a radioactive substance to a medicine. The medicine is called a . A somatostatin analogue is a man made (synthetic) version of somatostatin. This radioactive treatment circulates through your body in the bloodstream. It attaches to the somatostatin receptors on the NET cells. The radioactive treatment then enters the cell and kills it from the inside.
Doctors usually use a treatment called lutetium oxodotreotide (Lutathera).
You have special scans such as or . These can check whether your NET has somatostatin receptors. If it does, your doctors might offer you this treatment for a NET that:
started in your or
has spread or cannot be removed with surgery
is grade 1 or grade 2 - this means the NET is slow or moderately fast growing
You see a doctor and have blood tests and a physical examination. Your doctor might ask you to stop octreotide or lanreotide injections. If you have these every day, you might stop them for 12 hours before the treatment. If you are have them every month, your doctor might ask you to stop a month before the treatment.
Your doctor or specialist nurse will tell you which drugs you need to stop before the treatment.
You usually have treatment in the nuclear medicine department. It can take around 5 hours.
A doctor puts a small tube (cannula) into your arm or back of your hand. They then attach a drip of to the cannula. This helps to protect the kidneys from the radioactive treatment.
You have the drip of amino acids for one hour and then you start the radioactive drip. It takes about 30 minutes to have it.
After the radioactive drip, you continue to have the amino acids infusion for another 3 hours.
You usually have PRRT every 2 to 3 months. You have up to 4 doses of treatment.
After PRRT, you will be slightly radioactive. So you might need to stay in hospital for 1 or 2 days to make sure the radioactivity drops to a safe level before you go home. In some hospitals, you may be able to go home later the same day if you are feeling well.
You usually have special scans to check how much radiation is left in your body.
After you go home, there are still some safety precautions that you need to follow. Your doctor or specialist nurse will tell you about them and how long you need to do them for. The precautions might include:
avoiding close contact, such as hugging with young children and pregnant women
double flushing the toilet
sleeping in a separate bed to your partner
PRRT can cause side effects. These include:
You might have a drop in the number of blood cells such as red blood cells, white blood cells and platelets. This can increase your risk of breathlessness, infection and bleeding.
This is usually caused by the amino acids drip. You have anti sickness medicine before the start of treatment to help with this.
This can happen because your body gets rid of the radiation through the kidneys. You have a drip of amino acids before and after the treatment. This is to protect the kidneys from the effect of the radiation.
Pain can be caused by swelling (oedema) around the NET. Tell your doctor or nurse if you have this, they can give you medicines such as painkillers and steroids to help.
You might feel very tired and as though you lack energy.
After you finish treatment, you have regular blood tests. These check how well your kidneys are working and the levels of blood cells in your body.
You usually have blood tests every week or every 2 weeks for the first 2 months. You then have blood tests less often. You may have them at the hospital or at your GP surgery.
Treatment for neuroendocrine cancer can be difficult to cope with for some people. Your nurse will give you phone numbers to call if you have any problems at home.
Find out more about coping with a neuroendocrine cancer and how to get support
Last reviewed: 07 Feb 2025
Next review due: 07 Feb 2028
Radioisotope therapy uses radioactive medicines to treat some types of cancer. It is also known as radionuclide therapy. You have the radioisotope as a drink, capsule or injection.
Treatment depends on the type of neuroendocrine cancer you have, where it is, its size and whether it has spread (the stage).
Neuroendocrine cancers are also called neuroendocrine neoplasms (NENs). There are 2 key groups - neuroendocrine tumours (NETs) and neuroendocrine carcinomas (NECs).
Practical and emotional support is available to help you cope with neuroendocrine cancer.
Neuroendocrine cancers develop in cells of the neuroendocrine system. They can develop in different parts of the body including the lungs, stomach, pancreas and bowel.
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
